A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147
Last updated 2016-11-18
Summary
The purpose of this study is to estimate the change in sodium fluorescein staining, as a sign of dry eye, during six weeks of treatment with FID 115958D or Refresh Liquigel.
Conditions
- Dry Eye
Interventions
- OTHER
-
Lubricant Eye Drop
1 drop in each eye, four times a day for 42 days
- OTHER
-
Refresh Liquigel
1 drop in each eye, four times a day for 42 days
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
More Related Trials
-
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
NCT00848068 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 ·Status: COMPLETED ·Phase: PHASE3
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of FID 119515A
NCT01833117 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
NCT06660290 ·Status: COMPLETED ·Phase: PHASE3
-
Safety/Efficacy of Systane Free vs Refresh Tears
NCT00348322 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop
NCT00243711 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355 ·Status: COMPLETED
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02965846 ·Status: TERMINATED ·Phase: PHASE3
-
Objective Evaluation of Ocular Surface Lubricants in Two Environments
NCT01375582 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
NCT05288582 ·Status: COMPLETED ·Phase: NA
-
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
NCT01808560 ·Status: COMPLETED ·Phase: NA
-
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
NCT00893139 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
NCT01160133 ·Status: COMPLETED ·Phase: NA
-
Treatment Regimens in Meibomian Gland Dysfunction
NCT05594745 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
NCT01135511 ·Status: COMPLETED ·Phase: PHASE2